{"SPADE_UN_04305": {"Clinical Information": [], "Patent Information": [{"Patent No": "US 2010/0048469 A1", "Patent Link": "http://www.lens.org/lens/patent/US_2010_0048469_A1", "Patent Type": "Patent Application", "Publication Date": "2010-2-25", "Family Info": "EP2010561A1,EP2010561A4,EP2277899A2,EP2277899A3,WO2007126392A1,WO2007126392A8", "Patent Title": "There is provided at least one isolated antimicrobial peptide, wherein the peptide is a linear analog of hBD3 or a fragment thereof. In parti", "Abstract": "There is provided at least one isolated antimicrobial peptide, wherein the peptide is a linear analog of hBD3 or a fragment thereof. In particular, there is provided a linear analog of hBD3 wherein the peptide has a reduced cytotoxicity to at least one cell compared to the wild type hBD3."}], "Sequence Information": {"SPADE ID": "SPADE_UN_04305", "Sequence": "GIINTLQKYYXRVRGGR", "Sequence Length": 17, "Peptide Name": "Sequence 12 from Patent US 20100048469", "Source": "Synthetic construct", "Biological Activity": ["Antimicrobial"], "Frequent Amino Acids": "GRI", "Absent Amino Acids": "ACDEFHMOPSUW", "Basic Residues": 4, "Acidic Residues": 0, "Hydrophobic Residues": 6, "Polar Residues": 10, "Positive Residues": 4, "Negative Residues": 0, "Similar Sequences": [{"SPADE_ID": "SPADE_N_02301", "Similarity": 1.0, "Sequence": "GIINTLQKYYCRVRGGRCAVLTCLPKEEQIGKCSTRGRKCCRRKK"}, {"SPADE_ID": "SPADE_N_03155", "Similarity": 1.0, "Sequence": "GIINTLQKYYCRVRGGRCAVLSCLPKEEQIGKCSTRGRKCCRRKK"}, {"SPADE_ID": "SPADE_N_03973", "Similarity": 1.0, "Sequence": "GIINTLQKYYCRVRGGRCAVLTCLPKEEQIGKCSTRGRKCCR"}]}}}